These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacological and genetic analysis of mechanisms underlying detrusor overactivity in rats. Yokoyama O Neurourol Urodyn; 2010; 29(1):107-11. PubMed ID: 20025014 [TBL] [Abstract][Full Text] [Related]
6. Effects of antimuscarinics on voiding function after cerebral infarction in a rat model of overactive bladder. Yusup A; Akino H; Miwa Y; Oyama N; Aoki Y; Ito H; Tanase K; Matsuta Y; Nakai M; Yokoyama O Eur J Pharmacol; 2007 Dec; 577(1-3):143-9. PubMed ID: 17904547 [TBL] [Abstract][Full Text] [Related]
7. A new method for producing urinary bladder hyperactivity using a non-invasive transient intravesical infusion of acetic acid in conscious rats. Mitobe M; Inoue H; Westfall TD; Higashiyama H; Mizuyachi K; Kushida H; Kinoshita M J Pharmacol Toxicol Methods; 2008; 57(3):188-93. PubMed ID: 18367412 [TBL] [Abstract][Full Text] [Related]
8. Antimuscarinics and overactive bladder: other mechanism of action. Yamaguchi O Neurourol Urodyn; 2010; 29(1):112-5. PubMed ID: 19693952 [TBL] [Abstract][Full Text] [Related]
13. A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation. Wróbel A; Łańcut M; Rechberger T J Pharmacol Toxicol Methods; 2015; 74():7-16. PubMed ID: 25957030 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the effects of antimuscarinic agents on bladder functions in both nonhuman primates and rodents. Nagabukuro H; Villa KL; Wickham LA; Kulick AA; Gichuru L; Donnelly MJ; Voronin GO; Pereira T; Tong X; Nichols A; Alves SE; O'Neill GP; Johnson CV; Hickey EJ J Pharmacol Exp Ther; 2011 Jul; 338(1):220-7. PubMed ID: 21459965 [TBL] [Abstract][Full Text] [Related]
15. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats. Juszczak K; Ziomber A; Wyczolkowski M; Thor PJ J Physiol Pharmacol; 2009 Dec; 60(4):85-91. PubMed ID: 20065501 [TBL] [Abstract][Full Text] [Related]
16. Voiding behavior in awake unrestrained untethered spontaneously hypertensive and Wistar control rats. Langdale CL; Degoski D; Milliken PH; Grill WM Am J Physiol Renal Physiol; 2021 Aug; 321(2):F195-F206. PubMed ID: 34151591 [TBL] [Abstract][Full Text] [Related]
17. Researching bladder afferents-determining the effects of β(3) -adrenergic receptor agonists and botulinum toxin type-A. Kanai A; Wyndaele JJ; Andersson KE; Fry C; Ikeda Y; Zabbarova I; De Wachter S Neurourol Urodyn; 2011 Jun; 30(5):684-91. PubMed ID: 21661014 [TBL] [Abstract][Full Text] [Related]
18. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog. Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794 [TBL] [Abstract][Full Text] [Related]
19. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure. Yokoyama O; Miwa Y; Oyama N; Aoki Y; Ito H; Akino H J Urol; 2007 Nov; 178(5):2208-12. PubMed ID: 17870108 [TBL] [Abstract][Full Text] [Related]
20. An excitatory role for peripheral EP3 receptors in bladder afferent function. Su X; Lashinger ES; Leon LA; Hoffman BE; Hieble JP; Gardner SD; Fries HE; Edwards RM; Li J; Laping NJ Am J Physiol Renal Physiol; 2008 Aug; 295(2):F585-94. PubMed ID: 18562635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]